Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Modern Rheumatology|February 8, 2022
The efficacy and safety of anifrolumab in Japanese patients with systemic lupus erythematosus: TULIP-2 subanalysisYoshiya Tanaka, Tatsuya Atsumi, Masato Okada, et al.
Modern Rheumatology Case Reports|October 22, 2020
A case report, a case who developed limited cutaneous scleroderma and pulmonary hypertension 8 years after diagnosis of anti-centromere antibody-positive Sjögren syndromeMari Kyono, Masaki Okamoto, Satoshi Sakamoto, et al.
Modern Rheumatology|January 13, 2025
Disease activity and glucocorticoid tapering patterns in Japanese patients with systemic lupus erythematosus treated with anifrolumab: Post hoc analysis of the Japanese subpopulation of the TULIP-2 studyYoshiya Tanaka, Tatsuya Atsumi, Masato Okada, et al.
Medicina (Kaunas, Lithuania)|November 25, 2023
Successful Treatment of a Patient with Drug-Refractory Rheumatoid Arthritis-Associated Interstitial Lung Disease with Upadacitinib: A Case ReportYuuya Nishii, Masaki Okamoto, Yoshiaki Zaizen, et al.
Modern Rheumatology|September 14, 2023
The long-term safety and tolerability of anifrolumab for patients with systemic lupus erythematosus in Japan: TULIP-LTE subgroup analysisYoshiya Tanaka, Tatsuya Atsumi, Masato Okada, et al.
Modern Rheumatology|January 17, 2025
Efficacy of anifrolumab in systemic lupus erythematosus patients with serological manifestations: A post hoc analysis of the Japan subgroup of the TULIP-2 trialYoshiya Tanaka, Tatsuya Atsumi, Masato Okada, et al.
Modern Rheumatology|September 19, 2015
Safety, pharmacokinetics, and pharmacodynamics of epratuzumab in Japanese patients with moderate-to-severe systemic lupus erythematosus: Results from a phase 1/2 randomized studyTomomi Tsuru, Yoshiya Tanaka, Mitsumasa Kishimoto, et al.
Respiratory Research|November 1, 2025
Gene variants of interferon induced with helicase C domain 1 in Japanese patients with Dermatomyositis-associated rapidly progressive interstitial lung disease: a genetic association study using whole-exome and Sanger sequencingMasaki Okamoto, Akira Yoshida, Yoshiaki Zaizen, et al.
The Journal of Rheumatology|September 17, 2019
The Association of Airway Comorbidities With the Clinical Phenotypes and Outcomes of Patients With Antineutrophil Cytoplasmic Autoantibody-associated VasculitisNobuyuki Ono, Yasushi Inoue, Tomoya Miyamura, et al.
Arthritis Research & Therapy|June 1, 2022
Clinical course of patients with rheumatoid arthritis who continue or discontinue biologic therapy after hospitalization for infection: a retrospective observational studyYusuke Kashiwado, Chikako Kiyohara, Yasutaka Kimoto, et al.
Pageof 7